% Expired Patents = 35.7

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 39

Loading Chart...

5 inventors (with patents filed for the assignee):

Indu Parikh (14 out of 33 patents)

Kenneth B Adler (7 out of 10 patents)

Shuji Takashi (3 out of 3 patents)

4. Linda D Martin (3 out of 6 patents)

5. Yuehua Li (3 out of 5 patents)

14 patents: Sort by Forward Citations

1. 11466054 - Inhibitors of metastasis (2022-10-11),

2. 10683328 - Inhibitors of metastasis (2020-06-16),

3. 10011636 - Inhibitors of metastasis (2018-07-03),

4. 9827287 - Methods for attenuating release of inflammatory mediators and peptides useful therein (2017-11-28),

5. 9598463 - Mucin hypersecretion inhibitors and methods of use (2017-03-21),

6. 9408886 - Inhibitors of metastasis (2016-08-09),

7. 8999915 - Methods for attenuating release of inflammatory mediators and peptides useful therein (2015-04-07),

8. 8907056 - Mucin hypersecretion inhibitors and methods of use (2014-12-09),

9. 8563689 - Methods for regulating inflammatory mediators and peptides for useful therein (2013-10-22),

10. 8501911 - Methods of reducing inflammation and mucus hypersecretion (2013-08-06),

11. 8492518 - Mucin hypersecretion inhibitors and methods of use (2013-07-23),

12. 8293870 - Mucin hypersecretion inhibitors and methods of use (2012-10-23),

13. 7544772 - Methods for regulating inflammatory mediators and peptides useful therein (2009-06-09),

14. 7524926 - Mucin hypersecretion inhibitors and methods of use (2009-04-28),

Company Overview

Biomarck Pharmaceuticals Ltd. is a biopharmaceutical company based in Durham, North Carolina, specializing in the development of innovative therapies for various medical conditions. The organization focuses on leveraging advanced drug delivery systems and proprietary formulations to enhance treatment efficacy and patient outcomes. With a commitment to research and development, Biomarck aims to address unmet medical needs through its cutting-edge technologies and collaborative partnerships within the healthcare sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#56 in Durham, NC

#489 in North Carolina

#22,319 in US

#42,249 in the World

Durham, NC, United States of America

Biomarck Pharmaceuticals Ltd.

Forward Citations = 39

5 inventors:

Indu Parikh (14 out of 33 patents)

Kenneth B Adler (7 out of 10 patents)

Shuji Takashi (3 out of 3 patents)

4. Linda D Martin (3 out of 6 patents)

5. Yuehua Li (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomarck Pharmaceuticals Ltd.. Retrieved from https://idiyas.com/company/biomarck-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]